Prostate cancer gene therapy

Yasutomo Nasu, Hiromi Kumon

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)


With the advance in genetic engineering, tumor biology and immunology, gene therapy has been recognized as a promising new treatment option for cancer including prostate cancer. Several clinical trials of prostate cancer gene therapy are currently underway, using therapeutic genes which include suicide genes, immunomodulatory genes, tumor suppressor genes and anti-oncogenes. Although the gene therapy for prostate cancer as a clinical alternative is still early stage which requires several technological breakthrough, some information obtained from clinical trial indicates full potential of prostate cancer gene therapy. Concordant progress both in the basic research and gene therapy technology will make prostate cancer gene therapy ready for wide-scale of practice in the future. In this report, general concept and current progress in prostate cancer gene therapy are summarized.

Original languageEnglish
Pages (from-to)335-338
Number of pages4
JournalNippon rinsho. Japanese journal of clinical medicine
Issue number2
Publication statusPublished - Feb 2005

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Prostate cancer gene therapy'. Together they form a unique fingerprint.

Cite this